Cite
In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug?
MLA
Bieber, Thomas. “In Search of the Holy Grail in Atopic Dermatitis: Will Dupilumab Become the First Disease-Modifying Atopic Dermatitis Drug?” The Journal of Allergy and Clinical Immunology, vol. 151, no. 3, Mar. 2023, pp. 694–96. EBSCOhost, https://doi.org/10.1016/j.jaci.2022.12.824.
APA
Bieber, T. (2023). In search of the Holy Grail in atopic dermatitis: Will dupilumab become the first disease-modifying atopic dermatitis drug? The Journal of Allergy and Clinical Immunology, 151(3), 694–696. https://doi.org/10.1016/j.jaci.2022.12.824
Chicago
Bieber, Thomas. 2023. “In Search of the Holy Grail in Atopic Dermatitis: Will Dupilumab Become the First Disease-Modifying Atopic Dermatitis Drug?” The Journal of Allergy and Clinical Immunology 151 (3): 694–96. doi:10.1016/j.jaci.2022.12.824.